Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000950170-25-046209
Filing Date
2025-03-27
Accepted
2025-03-27 17:26:22
Documents
97
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 10-K drrx-20241231.htm   iXBRL 10-K 4041199
2 EX-10.22 drrx-ex10_22.htm EX-10.22 767574
3 EX-19.1 drrx-ex19_1.htm EX-19.1 128443
4 EX-23.1 drrx-ex23_1.htm EX-23.1 3625
5 EX-23.2 drrx-ex23_2.htm EX-23.2 8206
6 EX-31.1 drrx-ex31_1.htm EX-31.1 14501
7 EX-31.2 drrx-ex31_2.htm EX-31.2 14930
8 EX-32.1 drrx-ex32_1.htm EX-32.1 6390
9 EX-32.2 drrx-ex32_2.htm EX-32.2 6338
10 GRAPHIC img44792327_0.jpg GRAPHIC 14326
11 GRAPHIC img100814744_0.jpg GRAPHIC 68446
12 GRAPHIC img100814744_1.jpg GRAPHIC 87303
  Complete submission text file 0000950170-25-046209.txt   16691147

Data Files

Seq Description Document Type Size
13 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT drrx-20241231.xsd EX-101.SCH 1895283
100 EXTRACTED XBRL INSTANCE DOCUMENT drrx-20241231_htm.xml XML 2963643
Mailing Address 10240 BUBB ROAD CUPERTINO CA 95014
Business Address 10240 BUBB ROAD CUPERTINO CA 95014 4087771417
DURECT CORP (Filer) CIK: 0001082038 (see all company filings)

EIN.: 943297098 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-31615 | Film No.: 25780637
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)